Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
Saved in:
| Title: | Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia. |
|---|---|
| Authors: | Xu ZJ; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Jin Y; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China., Zhang XL; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China., Xia PH; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Wen XM; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Ma JC; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Lin J; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Qian J; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China. |
| Source: | Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 789-807. Date of Electronic Publication: 2022 May 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-7634 |
|---|---|
| DOI: | 10.1002/cam4.4905 |
